Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | ADORA1 | P30542 | 3/20 | 0.31 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.31 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10954666 | 0.82 | — | — | |
| SCHEMBL7087209 | 0.82 | PDE10A (0.35) | ADORA1ADORA2AADORA3HTTSMN1; SMN2 | |
| SCHEMBL2371337 | 0.80 | LMNA (0.39) | HSP90AB1LMNAADORA1ADORA2AADORA3 | |
| SCHEMBL8721097 | 0.78 | CCNA2 (0.33) | LMNA | |
| SCHEMBL8003108 | 0.75 | HSP90AB1 (0.30) | HSP90AB1 | |
| SCHEMBL6424033 | 0.73 | HSP90AB1 (0.36) | HSP90AB1LMNAADORA1ADORA2AADORA3 | |
| SCHEMBL1830380 | 0.73 | LMNA (0.40) | HSP90AB1LMNAHTTSMN1; SMN2 | |
| SCHEMBL16094459 | 0.71 | ADORA1 (0.39) | HSP90AB1LMNAADORA1ADORA2AADORA3 | |
| SCHEMBL5561175 | 0.71 | ALDH1A1 (0.31) | HSP90AB1SMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL5555790 | 0.69 | ALDH1A1 (0.31) | HSP90AB1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116116048-B | Preparation and use methods of ultrafiltration column | 杭州信海医药科技有限公司 | 2023-07-14 | — | — | CN | claimed |
| CN-116116048-A | Preparation and use methods of ultrafiltration column | 杭州信海医药科技有限公司 | 2023-05-16 | — | — | CN | claimed |
| CN-106243104-A | One is to naphthoquinone and pyrimidine heterozygote and synthetic method thereof | 新乡医学院 | 2016-12-21 | — | — | CN | claimed |
| US-6063895-A | BIODEGRADABLE, HEAT RESISTANT HIGH MOLECULAR WEIGHT POLYESTER (CO)POLYMER RESULTING FROM REACTION OF ADIPIC ACID, AMINE-FUNCTIONAL MONOMER, AND ETHYLENE GLYCOL AND/OR 1,4-BUTANEDIOL; MOLDING MATERIALS | IRE CHEMICAL LTD. (KR) | 2000-05-16 | — | — | US | claimed |
| CN-116116048-B | Preparation and use methods of ultrafiltration column | 杭州信海医药科技有限公司 | 2023-07-14 | — | — | CN | disclosed |
| CN-116116048-B | Preparation and use methods of ultrafiltration column | 杭州信海医药科技有限公司 | 2023-07-14 | — | — | CN | disclosed |
| CN-116116048-A | Preparation and use methods of ultrafiltration column | 杭州信海医药科技有限公司 | 2023-05-16 | — | — | CN | disclosed |
| CN-116116048-A | Preparation and use methods of ultrafiltration column | 杭州信海医药科技有限公司 | 2023-05-16 | — | — | CN | disclosed |
| CN-106243104-A | One is to naphthoquinone and pyrimidine heterozygote and synthetic method thereof | 新乡医学院 | 2016-12-21 | — | — | CN | disclosed |
| US-20090297795-A1 | Ink-Jet Printing Using Disazo Dyes | FUJIFILM IMAGING COLORANTS LIMITED (GB) | 2009-12-03 | — | — | US | disclosed |
| US-6919339-B2 | ABCA-1 elevating compounds | CV THEAPEUTICS, INC. (US) | 2005-07-19 | — | — | US | disclosed |
| EP-1341773-A2 | SUBSTITUTED 1,3,5-TRIAZINES AND PYRIMIDINES AS ABCA-1 ELEVATING COMPOUNDS AGAINST CORONARY ARTERY DISEASE OR ATHEROSCLEROSIS | CV THERAPEUTICS, INC. (US) | 2003-09-10 | — | — | EP | disclosed |
| US-20020128266-A1 | ABCA-1 elevating compounds | CV THERAPEUTICS, INC. | 2002-09-12 | — | — | US | disclosed |
| WO-2002046172-A2 | SUBSTITUTED 1, 3, 5-TRIAZINES AND PYRIMIDINES AS ABCA-1 ELEVATING COMPOUNDS AGAINST CORONARY ARTERY DISEASE OR ATHEROSCLEROSIS | CV THERAPEUTICS, INC. (US) | 2002-06-13 | — | — | WO | disclosed |
| US-6063895-A | BIODEGRADABLE, HEAT RESISTANT HIGH MOLECULAR WEIGHT POLYESTER (CO)POLYMER RESULTING FROM REACTION OF ADIPIC ACID, AMINE-FUNCTIONAL MONOMER, AND ETHYLENE GLYCOL AND/OR 1,4-BUTANEDIOL; MOLDING MATERIALS | IRE CHEMICAL LTD. (KR) | 2000-05-16 | — | — | US | disclosed |
| US-5213972-A | Production of thymidine and deoxyuridine, intermediates for AZT | CHEMGEN CORPORATION (US) | 1993-05-25 | — | — | US | disclosed |
| EP-0504279-A4 | FERMENTATION PROCESS FOR THE PRODUCTION OF PYRIMIDINE DEOXYRIBONUCLEOSIDES | — | 1993-02-17 | — | — | EP | disclosed |
| EP-0504279-A1 | FERMENTATION PROCESS FOR THE PRODUCTION OF PYRIMIDINE DEOXYRIBONUCLEOSIDES. | CHEMGEN CORP (US) | 1992-09-23 | — | — | EP | disclosed |
| WO-1991009130-A1 | FERMENTATION PROCESS FOR THE PRODUCTION OF PYRIMIDINE DEOXYRIBONUCLEOSIDES | CHEMGEN CORPORATION (US) | 1991-06-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020128266-A1 | ABCA-1 elevating compounds | ABCD3, ABCE1, ABCB4 | HSP90AB1 1191/4885LMNA 1603/4885ADORA1 247/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.